Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
A live webcast of the presentation will be available on the "Events & Presentations" page in the Investors section of the ...
Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...
Abu Dhabi introduces a revolutionary gene therapy for hemoglobinopathies, utilizing CRISPR-Cas9 technology. Explore how this ...
CRISPR/Cas9 gene-editing therapy is a groundbreaking technology that enables highly precise modification of disease-causing ...
The US FDA has approved the drug Mitapivat, marketed as Aqvesme, as the very first oral therapy for anemia in adults with ...
The US FDA has greenlit Mitapivat, the first oral treatment for anaemia in adults with thalassemia, marking a significant advancement in thalassemia care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback